PubMed:20663046
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-9 | 6711 | denotes | Melatonin |
T2 | 0-9 | D008550 | denotes | Melatonin |
T3 | 0-9 | D008550 | denotes | Melatonin |
T4 | 0-9 | CHEBI:16796 | denotes | Melatonin |
T5 | 32-38 | UBERON:0027368 | denotes | matrix |
T7 | 32-58 | P14780 | denotes | matrix metalloproteinase-9 |
T8 | 32-58 | P41246 | denotes | matrix metalloproteinase-9 |
T9 | 32-58 | P41245 | denotes | matrix metalloproteinase-9 |
T10 | 32-58 | P50282 | denotes | matrix metalloproteinase-9 |
T11 | 32-58 | PR:000010491 | denotes | matrix metalloproteinase-9 |
T12 | 32-58 | P52176 | denotes | matrix metalloproteinase-9 |
T13 | 32-58 | O18733 | denotes | matrix metalloproteinase-9 |
T6 | 32-58 | D020780 | denotes | matrix metalloproteinase-9 |
T14 | 60-63 | CHEBI:340824 | denotes | MMP |
T17 | 60-63 | CHEBI:59761 | denotes | MMP |
T18 | 60-65 | PR:P50282 | denotes | MMP-9 |
T19 | 60-65 | PR:P14780 | denotes | MMP-9 |
T20 | 60-65 | P14780 | denotes | MMP-9 |
T21 | 60-65 | PR:P41245 | denotes | MMP-9 |
T22 | 60-65 | P41246 | denotes | MMP-9 |
T23 | 60-65 | P41245 | denotes | MMP-9 |
T24 | 60-65 | PR:P52176 | denotes | MMP-9 |
T25 | 60-65 | P50282 | denotes | MMP-9 |
T27 | 60-65 | PR:000010491 | denotes | MMP-9 |
T28 | 60-65 | P52176 | denotes | MMP-9 |
T29 | 60-65 | O18733 | denotes | MMP-9 |
T26 | 60-65 | GO:0004229 | denotes | MMP-9 |
T30 | 101-112 | P33574 | denotes | plasminogen |
T31 | 101-112 | P20918 | denotes | plasminogen |
T32 | 101-112 | P06867 | denotes | plasminogen |
T34 | 101-112 | P83169 | denotes | plasminogen |
T35 | 101-112 | Q01177 | denotes | plasminogen |
T36 | 101-112 | PR:000012867 | denotes | plasminogen |
T37 | 101-112 | Q5R8X6 | denotes | plasminogen |
T38 | 101-112 | P81286 | denotes | plasminogen |
T39 | 101-112 | P06868 | denotes | plasminogen |
T40 | 101-112 | Q7M323 | denotes | plasminogen |
T41 | 101-112 | P12545 | denotes | plasminogen |
T43 | 101-112 | P80010 | denotes | plasminogen |
T44 | 101-112 | O18783 | denotes | plasminogen |
T45 | 101-112 | P80009 | denotes | plasminogen |
T46 | 101-112 | Q29485 | denotes | plasminogen |
T47 | 101-112 | P00747 | denotes | plasminogen |
T33 | 101-112 | CHEBI:8259 | denotes | plasminogen |
T42 | 101-112 | D010958 | denotes | plasminogen |
T48 | 113-120 | CHEBI:8258 | denotes | plasmin |
T49 | 113-120 | D005341 | denotes | plasmin |
T52 | 143-146 | PR:O04529 | denotes | MMP |
T50 | 143-146 | CHEBI:340824 | denotes | MMP |
T53 | 143-146 | CHEBI:59761 | denotes | MMP |
T51 | 143-146 | GO:0004235 | denotes | MMP |
T54 | 147-156 | CHEBI:35222 | denotes | inhibitor |
T55 | 160-164 | PR:000005054 | denotes | mice |
T57 | 160-164 | O89094 | denotes | mice |
T56 | 160-164 | D051379 | denotes | mice |
T58 | 160-164 | 10095 | denotes | mice |
T59 | 194-211 | D002545 | denotes | cerebral ischemia |
T60 | 194-211 | D002545 | denotes | cerebral ischemia |
T63 | 232-241 | 6711 | denotes | melatonin |
T64 | 232-241 | D008550 | denotes | melatonin |
T65 | 232-241 | D008550 | denotes | melatonin |
T66 | 232-241 | CHEBI:16796 | denotes | melatonin |
T67 | 253-259 | UBERON:0027368 | denotes | matrix |
T69 | 253-279 | P14780 | denotes | matrix metalloproteinase-9 |
T70 | 253-279 | P41246 | denotes | matrix metalloproteinase-9 |
T71 | 253-279 | P41245 | denotes | matrix metalloproteinase-9 |
T72 | 253-279 | P50282 | denotes | matrix metalloproteinase-9 |
T73 | 253-279 | PR:000010491 | denotes | matrix metalloproteinase-9 |
T74 | 253-279 | P52176 | denotes | matrix metalloproteinase-9 |
T75 | 253-279 | O18733 | denotes | matrix metalloproteinase-9 |
T68 | 253-279 | D020780 | denotes | matrix metalloproteinase-9 |
T76 | 281-284 | CHEBI:340824 | denotes | MMP |
T79 | 281-284 | CHEBI:59761 | denotes | MMP |
T80 | 281-286 | PR:P50282 | denotes | MMP-9 |
T81 | 281-286 | PR:P14780 | denotes | MMP-9 |
T82 | 281-286 | P14780 | denotes | MMP-9 |
T83 | 281-286 | PR:P41245 | denotes | MMP-9 |
T84 | 281-286 | P41246 | denotes | MMP-9 |
T85 | 281-286 | P41245 | denotes | MMP-9 |
T86 | 281-286 | PR:P52176 | denotes | MMP-9 |
T87 | 281-286 | P50282 | denotes | MMP-9 |
T89 | 281-286 | PR:000010491 | denotes | MMP-9 |
T90 | 281-286 | P52176 | denotes | MMP-9 |
T91 | 281-286 | O18733 | denotes | MMP-9 |
T88 | 281-286 | GO:0004229 | denotes | MMP-9 |
T92 | 362-379 | D002545 | denotes | cerebral ischemia |
T93 | 362-379 | D002545 | denotes | cerebral ischemia |
T96 | 448-459 | P33574 | denotes | plasminogen |
T97 | 448-459 | P20918 | denotes | plasminogen |
T98 | 448-459 | P06867 | denotes | plasminogen |
T100 | 448-459 | P83169 | denotes | plasminogen |
T101 | 448-459 | Q01177 | denotes | plasminogen |
T102 | 448-459 | PR:000012867 | denotes | plasminogen |
T103 | 448-459 | Q5R8X6 | denotes | plasminogen |
T104 | 448-459 | P81286 | denotes | plasminogen |
T105 | 448-459 | P06868 | denotes | plasminogen |
T106 | 448-459 | Q7M323 | denotes | plasminogen |
T107 | 448-459 | P12545 | denotes | plasminogen |
T109 | 448-459 | P80010 | denotes | plasminogen |
T110 | 448-459 | O18783 | denotes | plasminogen |
T111 | 448-459 | P80009 | denotes | plasminogen |
T112 | 448-459 | Q29485 | denotes | plasminogen |
T113 | 448-459 | P00747 | denotes | plasminogen |
T99 | 448-459 | CHEBI:8259 | denotes | plasminogen |
T108 | 448-459 | D010958 | denotes | plasminogen |
T114 | 460-467 | CHEBI:8258 | denotes | plasmin |
T115 | 460-467 | D005341 | denotes | plasmin |
T116 | 490-494 | D020782 | denotes | MMPs |
T117 | 495-504 | CHEBI:35222 | denotes | inhibitor |
T118 | 520-529 | 6711 | denotes | melatonin |
T119 | 520-529 | D008550 | denotes | melatonin |
T120 | 520-529 | D008550 | denotes | melatonin |
T121 | 520-529 | CHEBI:16796 | denotes | melatonin |
T122 | 539-542 | CHEBI:340824 | denotes | MMP |
T125 | 539-542 | CHEBI:59761 | denotes | MMP |
T126 | 539-544 | PR:P50282 | denotes | MMP-9 |
T127 | 539-544 | PR:P14780 | denotes | MMP-9 |
T128 | 539-544 | P14780 | denotes | MMP-9 |
T129 | 539-544 | PR:P41245 | denotes | MMP-9 |
T130 | 539-544 | P41246 | denotes | MMP-9 |
T131 | 539-544 | P41245 | denotes | MMP-9 |
T132 | 539-544 | PR:P52176 | denotes | MMP-9 |
T133 | 539-544 | P50282 | denotes | MMP-9 |
T135 | 539-544 | PR:000010491 | denotes | MMP-9 |
T136 | 539-544 | P52176 | denotes | MMP-9 |
T137 | 539-544 | O18733 | denotes | MMP-9 |
T134 | 539-544 | GO:0004229 | denotes | MMP-9 |
T138 | 557-561 | PR:000005054 | denotes | Mice |
T140 | 557-561 | O89094 | denotes | Mice |
T139 | 557-561 | D051379 | denotes | Mice |
T141 | 557-561 | 10095 | denotes | Mice |
T143 | 585-593 | D007511 | denotes | ischemia |
T144 | 585-593 | D007511 | denotes | ischemia |
T145 | 629-651 | UBERON:0001627 | denotes | middle cerebral artery |
T146 | 636-651 | D002539 | denotes | cerebral artery |
T148 | 636-651 | D002539 | denotes | cerebral artery |
T151 | 653-662 | D008550 | denotes | Melatonin |
T152 | 653-662 | D008550 | denotes | Melatonin |
T153 | 653-662 | CHEBI:16796 | denotes | Melatonin |
T154 | 653-668 | 332183 | denotes | Melatonin (5 mg |
T155 | 729-745 | D020520 | denotes | Brain infarction |
T156 | 729-745 | D020520 | denotes | Brain infarction |
T160 | 792-812 | GO:0031012 | denotes | Extracellular matrix |
T161 | 806-812 | UBERON:0027368 | denotes | matrix |
T162 | 870-877 | D007797 | denotes | laminin |
T166 | 878-885 | PR:000000001 | denotes | protein |
T164 | 878-885 | CHEBI:36080 | denotes | protein |
T165 | 878-885 | CHEBI:11122 | denotes | protein |
T167 | 878-885 | SO:0000104 | denotes | protein |
T163 | 878-885 | GO:0003675 | denotes | protein |
T168 | 918-921 | CHEBI:340824 | denotes | MMP |
T171 | 918-921 | CHEBI:59761 | denotes | MMP |
T172 | 918-923 | PR:P08253 | denotes | MMP-2 |
T173 | 918-923 | Q9GLE5 | denotes | MMP-2 |
T174 | 918-923 | P08253 | denotes | MMP-2 |
T175 | 918-923 | Q90611 | denotes | MMP-2 |
T177 | 918-923 | PR:Q8MPP3 | denotes | MMP-2 |
T178 | 918-923 | P33436 | denotes | MMP-2 |
T179 | 918-923 | PR:Q90611 | denotes | MMP-2 |
T180 | 918-923 | PR:P33436 | denotes | MMP-2 |
T181 | 918-923 | PR:000010479 | denotes | MMP-2 |
T182 | 918-923 | PR:P33434 | denotes | MMP-2 |
T183 | 918-923 | P33434 | denotes | MMP-2 |
T184 | 918-923 | P50757 | denotes | MMP-2 |
T176 | 918-923 | GO:0004228 | denotes | MMP-2 |
T185 | 928-931 | CHEBI:340824 | denotes | MMP |
T188 | 928-931 | CHEBI:59761 | denotes | MMP |
T189 | 928-933 | PR:P50282 | denotes | MMP-9 |
T190 | 928-933 | PR:P14780 | denotes | MMP-9 |
T191 | 928-933 | P14780 | denotes | MMP-9 |
T192 | 928-933 | PR:P41245 | denotes | MMP-9 |
T193 | 928-933 | P41246 | denotes | MMP-9 |
T194 | 928-933 | P41245 | denotes | MMP-9 |
T195 | 928-933 | PR:P52176 | denotes | MMP-9 |
T196 | 928-933 | P50282 | denotes | MMP-9 |
T198 | 928-933 | PR:000010491 | denotes | MMP-9 |
T199 | 928-933 | P52176 | denotes | MMP-9 |
T200 | 928-933 | O18733 | denotes | MMP-9 |
T197 | 928-933 | GO:0004229 | denotes | MMP-9 |
T201 | 953-960 | 4716 | denotes | gelatin |
T202 | 953-960 | D005780 | denotes | gelatin |
T203 | 953-960 | CHEBI:5291 | denotes | gelatin |
T204 | 1057-1063 | UBERON:0000479 | denotes | tissue |
T205 | 1068-1077 | D014568 | denotes | urokinase |
T206 | 1078-1089 | P33574 | denotes | plasminogen |
T207 | 1078-1089 | P20918 | denotes | plasminogen |
T208 | 1078-1089 | P06867 | denotes | plasminogen |
T210 | 1078-1089 | P83169 | denotes | plasminogen |
T211 | 1078-1089 | Q01177 | denotes | plasminogen |
T212 | 1078-1089 | PR:000012867 | denotes | plasminogen |
T213 | 1078-1089 | Q5R8X6 | denotes | plasminogen |
T214 | 1078-1089 | P81286 | denotes | plasminogen |
T215 | 1078-1089 | P06868 | denotes | plasminogen |
T216 | 1078-1089 | Q7M323 | denotes | plasminogen |
T217 | 1078-1089 | P12545 | denotes | plasminogen |
T219 | 1078-1089 | P80010 | denotes | plasminogen |
T220 | 1078-1089 | O18783 | denotes | plasminogen |
T221 | 1078-1089 | P80009 | denotes | plasminogen |
T222 | 1078-1089 | Q29485 | denotes | plasminogen |
T223 | 1078-1089 | P00747 | denotes | plasminogen |
T224 | 1078-1100 | D010960 | denotes | plasminogen activators |
T228 | 1102-1105 | Q28198 | denotes | tPA |
T230 | 1102-1105 | Q5R8J0 | denotes | tPA |
T231 | 1102-1105 | P19637 | denotes | tPA |
T232 | 1102-1105 | P00750 | denotes | tPA |
T233 | 1102-1105 | Q8SQ23 | denotes | tPA |
T235 | 1102-1105 | PR:000012825 | denotes | tPA |
T236 | 1102-1105 | P11214 | denotes | tPA |
T225 | 1102-1105 | CHEBI:53394 | denotes | tPA |
T226 | 1102-1105 | CHEBI:15702 | denotes | tPA |
T227 | 1102-1105 | CHEBI:61432 | denotes | tPA |
T229 | 1102-1105 | CHEBI:37537 | denotes | tPA |
T234 | 1102-1105 | GO:0031299 | denotes | tPA |
T237 | 1110-1113 | P06869 | denotes | uPA |
T238 | 1110-1113 | P29598 | denotes | uPA |
T239 | 1110-1113 | Q5RF29 | denotes | uPA |
T240 | 1110-1113 | PR:000013171 | denotes | uPA |
T241 | 1110-1113 | P04185 | denotes | uPA |
T242 | 1110-1113 | PR:000012826 | denotes | uPA |
T243 | 1110-1113 | Q8MHY7 | denotes | uPA |
T244 | 1110-1113 | P00749 | denotes | uPA |
T245 | 1110-1113 | PR:Q96NZ9 | denotes | uPA |
T246 | 1110-1113 | Q05589 | denotes | uPA |
T248 | 1110-1113 | P16227 | denotes | uPA |
T249 | 1110-1113 | PR:Q80XD8 | denotes | uPA |
T250 | 1110-1113 | P15120 | denotes | uPA |
T247 | 1110-1113 | GO:0008243 | denotes | uPA |
T251 | 1133-1144 | P33574 | denotes | plasminogen |
T252 | 1133-1144 | P20918 | denotes | plasminogen |
T253 | 1133-1144 | P06867 | denotes | plasminogen |
T255 | 1133-1144 | P83169 | denotes | plasminogen |
T256 | 1133-1144 | Q01177 | denotes | plasminogen |
T257 | 1133-1144 | PR:000012867 | denotes | plasminogen |
T258 | 1133-1144 | Q5R8X6 | denotes | plasminogen |
T259 | 1133-1144 | P81286 | denotes | plasminogen |
T260 | 1133-1144 | P06868 | denotes | plasminogen |
T261 | 1133-1144 | Q7M323 | denotes | plasminogen |
T262 | 1133-1144 | P12545 | denotes | plasminogen |
T264 | 1133-1144 | P80010 | denotes | plasminogen |
T265 | 1133-1144 | O18783 | denotes | plasminogen |
T266 | 1133-1144 | P80009 | denotes | plasminogen |
T267 | 1133-1144 | Q29485 | denotes | plasminogen |
T268 | 1133-1144 | P00747 | denotes | plasminogen |
T254 | 1133-1144 | CHEBI:8259 | denotes | plasminogen |
T263 | 1133-1144 | D010958 | denotes | plasminogen |
T270 | 1155-1161 | 862460 | denotes | casein |
T269 | 1155-1161 | CHEBI:3448 | denotes | casein |
T271 | 1155-1161 | D002364 | denotes | casein |
T290 | 1185-1206 | P17811 | denotes | plasminogen activator |
T291 | 1185-1206 | D010960 | denotes | plasminogen activator |
T292 | 1207-1216 | CHEBI:35222 | denotes | inhibitor |
T293 | 1218-1221 | P22777 | denotes | PAI |
T294 | 1218-1221 | P13909 | denotes | PAI |
T295 | 1218-1221 | P05121 | denotes | PAI |
T296 | 1218-1221 | P50449 | denotes | PAI |
T297 | 1218-1221 | P79335 | denotes | PAI |
T299 | 1218-1221 | P20961 | denotes | PAI |
T300 | 1218-1221 | PR:000014702 | denotes | PAI |
T298 | 1218-1221 | CVCL_0479 | denotes | PAI |
T301 | 1218-1221 | CVCL_J288 | denotes | PAI |
T302 | 1227-1233 | UBERON:0000479 | denotes | tissue |
T303 | 1234-1244 | CHEBI:35222 | denotes | inhibitors |
T306 | 1248-1251 | PR:O04529 | denotes | MMP |
T304 | 1248-1251 | CHEBI:340824 | denotes | MMP |
T307 | 1248-1251 | CHEBI:59761 | denotes | MMP |
T305 | 1248-1251 | GO:0004235 | denotes | MMP |
T312 | 1253-1259 | P81546 | denotes | TIMP-1 |
T313 | 1253-1259 | O02722 | denotes | TIMP-1 |
T314 | 1253-1259 | P49061 | denotes | TIMP-1 |
T315 | 1253-1259 | P50122 | denotes | TIMP-1 |
T316 | 1253-1259 | P20614 | denotes | TIMP-1 |
T317 | 1253-1259 | P12032 | denotes | TIMP-1 |
T318 | 1253-1259 | P35624 | denotes | TIMP-1 |
T319 | 1253-1259 | P20414 | denotes | TIMP-1 |
T320 | 1253-1259 | Q95KL9 | denotes | TIMP-1 |
T321 | 1253-1259 | Q5RC60 | denotes | TIMP-1 |
T322 | 1253-1259 | PR:P30120 | denotes | TIMP-1 |
T323 | 1253-1259 | P30120 | denotes | TIMP-1 |
T324 | 1253-1259 | PR:000016352 | denotes | TIMP-1 |
T326 | 1253-1259 | PR:P12032 | denotes | TIMP-1 |
T327 | 1253-1259 | PR:P01033 | denotes | TIMP-1 |
T328 | 1253-1259 | P01033 | denotes | TIMP-1 |
T325 | 1253-1259 | D019715 | denotes | TIMP-1 |
T329 | 1374-1391 | D002545 | denotes | Cerebral ischemia |
T330 | 1374-1391 | D002545 | denotes | Cerebral ischemia |
T333 | 1422-1425 | CHEBI:340824 | denotes | MMP |
T336 | 1422-1425 | CHEBI:59761 | denotes | MMP |
T337 | 1422-1427 | PR:P50282 | denotes | MMP-9 |
T338 | 1422-1427 | PR:P14780 | denotes | MMP-9 |
T339 | 1422-1427 | P14780 | denotes | MMP-9 |
T340 | 1422-1427 | PR:P41245 | denotes | MMP-9 |
T341 | 1422-1427 | P41246 | denotes | MMP-9 |
T342 | 1422-1427 | P41245 | denotes | MMP-9 |
T343 | 1422-1427 | PR:P52176 | denotes | MMP-9 |
T344 | 1422-1427 | P50282 | denotes | MMP-9 |
T346 | 1422-1427 | PR:000010491 | denotes | MMP-9 |
T347 | 1422-1427 | P52176 | denotes | MMP-9 |
T348 | 1422-1427 | O18733 | denotes | MMP-9 |
T345 | 1422-1427 | GO:0004229 | denotes | MMP-9 |
T349 | 1511-1520 | 6711 | denotes | melatonin |
T350 | 1511-1520 | D008550 | denotes | melatonin |
T351 | 1511-1520 | D008550 | denotes | melatonin |
T352 | 1511-1520 | CHEBI:16796 | denotes | melatonin |
T353 | 1565-1568 | CHEBI:340824 | denotes | MMP |
T356 | 1565-1568 | CHEBI:59761 | denotes | MMP |
T357 | 1565-1570 | PR:P50282 | denotes | MMP-9 |
T358 | 1565-1570 | PR:P14780 | denotes | MMP-9 |
T359 | 1565-1570 | P14780 | denotes | MMP-9 |
T360 | 1565-1570 | PR:P41245 | denotes | MMP-9 |
T361 | 1565-1570 | P41246 | denotes | MMP-9 |
T362 | 1565-1570 | P41245 | denotes | MMP-9 |
T363 | 1565-1570 | PR:P52176 | denotes | MMP-9 |
T364 | 1565-1570 | P50282 | denotes | MMP-9 |
T366 | 1565-1570 | PR:000010491 | denotes | MMP-9 |
T367 | 1565-1570 | P52176 | denotes | MMP-9 |
T368 | 1565-1570 | O18733 | denotes | MMP-9 |
T365 | 1565-1570 | GO:0004229 | denotes | MMP-9 |
T369 | 1628-1633 | UBERON:6110636 | denotes | brain |
T370 | 1628-1633 | UBERON:0000955 | denotes | brain |
T371 | 1628-1644 | D020520 | denotes | brain infarction |
T372 | 1628-1644 | D020520 | denotes | brain infarction |
T375 | 1696-1703 | D007797 | denotes | laminin |
T380 | 1704-1711 | SO:0000104 | denotes | protein |
T379 | 1704-1711 | PR:000000001 | denotes | protein |
T376 | 1704-1711 | GO:0003675 | denotes | protein |
T377 | 1704-1711 | CHEBI:36080 | denotes | protein |
T378 | 1704-1711 | CHEBI:11122 | denotes | protein |
T381 | 1731-1740 | 6711 | denotes | melatonin |
T382 | 1731-1740 | D008550 | denotes | melatonin |
T383 | 1731-1740 | D008550 | denotes | melatonin |
T384 | 1731-1740 | CHEBI:16796 | denotes | melatonin |
T385 | 1750-1753 | CHEBI:340824 | denotes | MMP |
T388 | 1750-1753 | CHEBI:59761 | denotes | MMP |
T389 | 1750-1755 | PR:P50282 | denotes | MMP-9 |
T390 | 1750-1755 | PR:P14780 | denotes | MMP-9 |
T391 | 1750-1755 | P14780 | denotes | MMP-9 |
T392 | 1750-1755 | PR:P41245 | denotes | MMP-9 |
T393 | 1750-1755 | P41246 | denotes | MMP-9 |
T394 | 1750-1755 | P41245 | denotes | MMP-9 |
T395 | 1750-1755 | PR:P52176 | denotes | MMP-9 |
T396 | 1750-1755 | P50282 | denotes | MMP-9 |
T398 | 1750-1755 | PR:000010491 | denotes | MMP-9 |
T399 | 1750-1755 | P52176 | denotes | MMP-9 |
T400 | 1750-1755 | O18733 | denotes | MMP-9 |
T397 | 1750-1755 | GO:0004229 | denotes | MMP-9 |
T401 | 1794-1797 | P06869 | denotes | uPA |
T402 | 1794-1797 | P29598 | denotes | uPA |
T403 | 1794-1797 | Q5RF29 | denotes | uPA |
T404 | 1794-1797 | PR:000013171 | denotes | uPA |
T405 | 1794-1797 | P04185 | denotes | uPA |
T406 | 1794-1797 | PR:000012826 | denotes | uPA |
T407 | 1794-1797 | Q8MHY7 | denotes | uPA |
T408 | 1794-1797 | P00749 | denotes | uPA |
T409 | 1794-1797 | PR:Q96NZ9 | denotes | uPA |
T410 | 1794-1797 | Q05589 | denotes | uPA |
T412 | 1794-1797 | P16227 | denotes | uPA |
T413 | 1794-1797 | PR:Q80XD8 | denotes | uPA |
T414 | 1794-1797 | P15120 | denotes | uPA |
T411 | 1794-1797 | GO:0008243 | denotes | uPA |
T419 | 1838-1844 | P81546 | denotes | TIMP-1 |
T420 | 1838-1844 | O02722 | denotes | TIMP-1 |
T421 | 1838-1844 | P49061 | denotes | TIMP-1 |
T422 | 1838-1844 | P50122 | denotes | TIMP-1 |
T423 | 1838-1844 | P20614 | denotes | TIMP-1 |
T424 | 1838-1844 | P12032 | denotes | TIMP-1 |
T425 | 1838-1844 | P35624 | denotes | TIMP-1 |
T426 | 1838-1844 | P20414 | denotes | TIMP-1 |
T427 | 1838-1844 | Q95KL9 | denotes | TIMP-1 |
T428 | 1838-1844 | Q5RC60 | denotes | TIMP-1 |
T429 | 1838-1844 | PR:P30120 | denotes | TIMP-1 |
T430 | 1838-1844 | P30120 | denotes | TIMP-1 |
T431 | 1838-1844 | PR:000016352 | denotes | TIMP-1 |
T433 | 1838-1844 | PR:P12032 | denotes | TIMP-1 |
T434 | 1838-1844 | PR:P01033 | denotes | TIMP-1 |
T435 | 1838-1844 | P01033 | denotes | TIMP-1 |
T432 | 1838-1844 | D019715 | denotes | TIMP-1 |
T436 | 1860-1863 | P22777 | denotes | PAI |
T437 | 1860-1863 | P13909 | denotes | PAI |
T438 | 1860-1863 | P05121 | denotes | PAI |
T439 | 1860-1863 | P50449 | denotes | PAI |
T440 | 1860-1863 | P79335 | denotes | PAI |
T442 | 1860-1863 | P20961 | denotes | PAI |
T443 | 1860-1863 | PR:000014702 | denotes | PAI |
T441 | 1860-1863 | CVCL_0479 | denotes | PAI |
T444 | 1860-1863 | CVCL_J288 | denotes | PAI |
T445 | 1927-1936 | 6711 | denotes | melatonin |
T446 | 1927-1936 | D008550 | denotes | melatonin |
T447 | 1927-1936 | D008550 | denotes | melatonin |
T448 | 1927-1936 | CHEBI:16796 | denotes | melatonin |
T449 | 1991-1994 | CHEBI:340824 | denotes | MMP |
T452 | 1991-1994 | CHEBI:59761 | denotes | MMP |
T453 | 1991-1996 | PR:P50282 | denotes | MMP-9 |
T454 | 1991-1996 | PR:P14780 | denotes | MMP-9 |
T455 | 1991-1996 | P14780 | denotes | MMP-9 |
T456 | 1991-1996 | PR:P41245 | denotes | MMP-9 |
T457 | 1991-1996 | P41246 | denotes | MMP-9 |
T458 | 1991-1996 | P41245 | denotes | MMP-9 |
T459 | 1991-1996 | PR:P52176 | denotes | MMP-9 |
T460 | 1991-1996 | P50282 | denotes | MMP-9 |
T462 | 1991-1996 | PR:000010491 | denotes | MMP-9 |
T463 | 1991-1996 | P52176 | denotes | MMP-9 |
T464 | 1991-1996 | O18733 | denotes | MMP-9 |
T461 | 1991-1996 | GO:0004229 | denotes | MMP-9 |
T465 | 2063-2066 | PR:A5I0I2 | denotes | add |
T466 | 2063-2066 | PR:P22333 | denotes | add |
T467 | 2063-2066 | PR:Q54KF3 | denotes | add |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 213-392 | DRI_Outcome | denotes | We have shown that melatonin attenuated matrix metalloproteinase-9 (MMP-9) activation and decreased the risk of hemorrhagic transformation following cerebral ischemia-reperfusion. |
T2 | 393-519 | DRI_Outcome | denotes | Herein, we investigate the possible involvement of the plasminogen/plasmin system and endogenous MMPs inhibitor underlying the |
T3 | 545-556 | DRI_Outcome | denotes | inhibition. |
T4 | 557-652 | DRI_Background | denotes | Mice were subjected to 1-hr ischemia and 48-hr reperfusion of the right middle cerebral artery. |
T5 | 653-728 | DRI_Background | denotes | Melatonin (5 mg/kg) or vehicle was intravenously injected upon reperfusion. |
T6 | 729-791 | DRI_Background | denotes | Brain infarction and hemorrhagic transformation were measured. |
T7 | 792-886 | DRI_Approach | denotes | Extracellular matrix damage was determined by Western immunoblot analysis for laminin protein. |
T8 | 887-1025 | DRI_Background | denotes | The activity and expression of MMP-2 and MMP-9 were determined by gelatin zymography, in situ zymography, and Western immunoblot analysis. |
T9 | 1026-1173 | DRI_Background | denotes | In addition, the activities of tissue and urokinase plasminogen activators (tPA and uPA) were evaluated by plasminogen-dependent casein zymography. |
T10 | 1174-1373 | DRI_Background | denotes | Endogenous plasminogen activator inhibitor (PAI) and tissue inhibitors of MMP (TIMP-1) were investigated using enzyme-linked immunosorbent assay (ELISA) and Western immunoblot analysis, respectively. |
T11 | 1374-1488 | DRI_Background | denotes | Cerebral ischemia-reperfusion induced increased MMP-9 activity and expression at 12-48 hr after reperfusion onset. |
T12 | 1489-1725 | DRI_Outcome | denotes | Relative to controls, melatonin-treated animals had significantly decreased MMP-9 activity and expression (P<0.05), in addition to reduced brain infarction and hemorrhagic transformation as well as improved laminin protein preservation. |
T13 | 1726-1730 | DRI_Outcome | denotes | This |
T14 | 1756-1896 | DRI_Outcome | denotes | inhibition was accompanied by reduced uPA activity (P<0.05), as well as increased TIMP-1 expression and PAI activity (P<0.05, respectively). |
T15 | 1897-1977 | DRI_Challenge | denotes | These results demonstrate the melatonin's pluripotent mechanisms for attenuating |
T16 | 1997-2123 | DRI_Challenge | denotes | activation and neurovascular damage, and further support it as an add-on to thrombolytic therapy for ischemic stroke patients. |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 362-379 | HP_0002637 | denotes | cerebral ischemia |
T2 | 1374-1391 | HP_0002637 | denotes | Cerebral ischemia |
T3 | 2098-2113 | HP_0002140 | denotes | ischemic stroke |
T4 | 2107-2113 | HP_0001297 | denotes | stroke |
Allie
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
SS1_20663046_0_0 | 32-58 | expanded | denotes | matrix metalloproteinase-9 |
SS2_20663046_0_0 | 60-65 | abbr | denotes | MMP-9 |
SS1_20663046_1_0 | 253-279 | expanded | denotes | matrix metalloproteinase-9 |
SS2_20663046_1_0 | 281-286 | abbr | denotes | MMP-9 |
SS1_20663046_9_0 | 1185-1216 | expanded | denotes | plasminogen activator inhibitor |
SS2_20663046_9_0 | 1218-1221 | abbr | denotes | PAI |
SS1_20663046_9_1 | 1285-1318 | expanded | denotes | enzyme-linked immunosorbent assay |
SS2_20663046_9_1 | 1320-1325 | abbr | denotes | ELISA |
AE1_20663046_0_0 | SS1_20663046_0_0 | SS2_20663046_0_0 | abbreviatedTo | matrix metalloproteinase-9,MMP-9 |
AE1_20663046_1_0 | SS1_20663046_1_0 | SS2_20663046_1_0 | abbreviatedTo | matrix metalloproteinase-9,MMP-9 |
AE1_20663046_9_0 | SS1_20663046_9_0 | SS2_20663046_9_0 | abbreviatedTo | plasminogen activator inhibitor,PAI |
AE1_20663046_9_1 | SS1_20663046_9_1 | SS2_20663046_9_1 | abbreviatedTo | enzyme-linked immunosorbent assay,ELISA |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-212 | DRI_Background | denotes | Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. |
T2 | 213-392 | DRI_Outcome | denotes | We have shown that melatonin attenuated matrix metalloproteinase-9 (MMP-9) activation and decreased the risk of hemorrhagic transformation following cerebral ischemia-reperfusion. |
T3 | 393-519 | DRI_Outcome | denotes | Herein, we investigate the possible involvement of the plasminogen/plasmin system and endogenous MMPs inhibitor underlying the |
T4 | 520-544 | Token_Label.OUTSIDE | denotes | melatonin-mediated MMP-9 |
T5 | 545-556 | DRI_Outcome | denotes | inhibition. |
T6 | 557-652 | DRI_Background | denotes | Mice were subjected to 1-hr ischemia and 48-hr reperfusion of the right middle cerebral artery. |
T7 | 653-728 | DRI_Background | denotes | Melatonin (5 mg/kg) or vehicle was intravenously injected upon reperfusion. |
T8 | 729-791 | DRI_Background | denotes | Brain infarction and hemorrhagic transformation were measured. |
T9 | 792-886 | DRI_Approach | denotes | Extracellular matrix damage was determined by Western immunoblot analysis for laminin protein. |
T10 | 887-1025 | DRI_Background | denotes | The activity and expression of MMP-2 and MMP-9 were determined by gelatin zymography, in situ zymography, and Western immunoblot analysis. |
T11 | 1026-1173 | DRI_Background | denotes | In addition, the activities of tissue and urokinase plasminogen activators (tPA and uPA) were evaluated by plasminogen-dependent casein zymography. |
T12 | 1174-1373 | DRI_Background | denotes | Endogenous plasminogen activator inhibitor (PAI) and tissue inhibitors of MMP (TIMP-1) were investigated using enzyme-linked immunosorbent assay (ELISA) and Western immunoblot analysis, respectively. |
T13 | 1374-1488 | DRI_Background | denotes | Cerebral ischemia-reperfusion induced increased MMP-9 activity and expression at 12-48 hr after reperfusion onset. |
T14 | 1489-1725 | DRI_Outcome | denotes | Relative to controls, melatonin-treated animals had significantly decreased MMP-9 activity and expression (P<0.05), in addition to reduced brain infarction and hemorrhagic transformation as well as improved laminin protein preservation. |
T15 | 1726-1730 | DRI_Outcome | denotes | This |
T16 | 1731-1755 | Token_Label.OUTSIDE | denotes | melatonin-mediated MMP-9 |
T17 | 1756-1896 | DRI_Outcome | denotes | inhibition was accompanied by reduced uPA activity (P<0.05), as well as increased TIMP-1 expression and PAI activity (P<0.05, respectively). |
T18 | 1897-1977 | DRI_Challenge | denotes | These results demonstrate the melatonin's pluripotent mechanisms for attenuating |
T19 | 1978-1996 | Token_Label.OUTSIDE | denotes | postischemic MMP-9 |
T20 | 1997-2123 | DRI_Challenge | denotes | activation and neurovascular damage, and further support it as an add-on to thrombolytic therapy for ischemic stroke patients. |